Older AdultsSEATNCT03732729
Clinical Effect of Massage Chair on Older Adults
A study testing massage chair in people with Older Adults, run by Eunju Lee at 1 site in South Korea.
Trial summary
The use of massage chairs is becoming more popular in many countries. According to the previous reports, some manual massages have positive effects on the mood, pain, fatigue, and sleep quality. However, the clinical benefits of the massage chair have not been fully understood. Read more about this study
- Who is it for?
- Ages 50 to 75 yearsHealthy volunteers can take part
- Conditions the study is for
- Older Adults
- What is being tested?
- massage chair
- Type of treatment
- Medical device
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 80 participants
- Where
- 1 siteSouth Korea
- Study dates
- 11 Dec 2018to 16 Apr 2020
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 50 to 75 years
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- Community-dwelling healthy adults between 50-75 years old
Who cannot join
- Unable to sign his/her own informed consent
- Any disability or damages in 4 extremity.
- Who have exercised regularly more than twice a week during the last 24 weeks
- Who have received regular massage during the last 24 weeks
- Confirmed osteoporosis of T score <-2.5 from BMD or history of compression fracture
- Cortisol-metabolism disorders or other diseases that can affect steroid secretion
Show all 9Show fewer
- Who have taken any medication related with steroid secretion or metabolism within 2 weeks
- Expected life expectancy less than 12 months (Symptomatic heart failure, end-stage renal failure)
- Spouse is already enrolled in this research
Trial locations and contacts
1 site in 1 country.
About this study
Official title: A Study for Evaluation of Massage Chair in Community-dwelling Older Adults: Randomized Study
The use of massage chairs is becoming more popular in many countries. According to the previous reports, some manual massages have positive effects on the mood, pain, fatigue, and sleep quality. However, the clinical benefits of the massage chair have not been fully understood. In this trial, it is aimed to evaluate the clinical effectiveness of the 6-month regular use of massage chair twice a day. It is hypothesized that long-term regular use of massage chair has positive effects on the hormonal level related to the stress, inflammation, and aging, as well as physical, psychologic, and muscle quality.
Read the detailed description
A total of enrolled 80 patients after randomization(1:1) in intervention(Massage chair)group and Control groups, will be provided
- Massage chair group
- lifestyle modification education + using massage chair twice per day during 24weeks
- control group: only lifestyle modification education
- Screening visit
- collection demographic data, BMD, vital sign, Medication history
- Visit 1 (0-week)
- Vital sign
- Charlson comorbidity index
- Laboratory test
- WBC diff count, Hb, creatinine, ALT, albumin, hsCRP, ESR cortisol, serotonin, DHEA-s, IGF-1, NK cell, Telomere length
- Questionnaire: K-MMSE, SGDS-K, BEPSI-K, EQ-5D-5L
- Physical\& muscular assessment
- SPPB, Grip strength, Muscle tone, Bioimpedance analysis
- Visit 2-6 (4,8,12,16 weeks) via Phone contact: assess compliance and adverse events
- visit 7 (24weeks)
- Vital sign
- Laboratory test
- WBC diff count, Hb, creatinine, ALT, albumin, hsCRP, ESR cortisol, serotonin, DHEA-s, IGF-1, NK cell, Telomere length
- Questionnaire: K-MMSE, SGDS-K, BEPSI-K, EQ-5D-5L
- Physical\& muscular assessment
- SPPB, Grip strength, Muscle tone, Bioimpedance analysis
- Compliance
- Adverse events
- Conditions
- Older Adults
- Being tested
- massage chair
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
massage chairDevice
Patient should use massage chair, twice per day, for 30minutes
| Study group | Role | What they receive |
|---|---|---|
| Massage chair | Experimental | lifestyle modification education(once)+ Using massage chair Receives: Device: massage chair |
| Control | No intervention | lifestyle modification education(once) |
What is being measured
The primary outcome is the main question the study is designed to answer.
Serum cortisol level
Investigate serum cortisol level of baseline \& 24weeks between 2 groups.
Measured: Change from baseline serum cortisol level at 24weeks
Secondary outcomes (11)
Cortisol/DHEA-s ratio
Investigate serum Cortisol/DHEA-s ratio level of baseline \& 24weeks between 2 groups.
Measured: Change from Baseline cortisol/DHEA-s ratio level at 24weeks
Serum Serotonin level
Investigate serum serotonin level of baseline \& 24weeks between 2 groups.
Measured: Change from Baseline serum serotonin level at 24weeks
Serum IGF-1 level
Investigate serum IGF-1 level of baseline \& 24weeks between 2 groups.
Measured: Change from Baseline Serum IGF-1 level level at 24weeks
ESR
Investigate serum ESR level of baseline \& 24weeks between 2 groups.
Measured: Change from Baseline ESR level at 24weeks
hsCRP
Investigate serum hsCRP level of baseline \& 24weeks between 2 groups.
Measured: Change from Baseline hs CRP level at 24weeks
NK cell activity
Investigate serum NK cell activity of baseline \& 24weeks between 2 groups.
Measured: Change from Baseline NK cell activity level at 24weeks
Telomere length
Investigate Telomere length of baseline \& 24weeks between 2 groups
Measured: Change from Baseline Telomere length level at 24weeks
Korean version Short form Geriatric Depression Scale(SGDS-K) score
15 item measure to assess the depression
Measured: SGDS-K summed total score is changed lower at 24weeks from baseline
Korean version -Brief Encounter Psychosocial Instrument(BEPSI-K) score
5 item measure to assess the Stress
Measured: BEPSI-K summed total score is changed lower at 24weeks from baseline
The 5-level EQ-5D version(EQ-5D-5L) score
6 item measure to assess the quality of life
Measured: EQ-5D-5L summed total score is changed higher at 24weeks from baseline
Muscle tone score
6 item measure to assess Muscle tone of both trapezoid\& forearm \& thigh
Measured: Individual site Muscle tone score is changed higher at 24weeks from baseline
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted7 Nov 2018
- Study start11 Dec 2018
- Primary completion16 Apr 2020
- Study completion16 Apr 2020
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Older AdultsStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Health services research
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 80 participants (actual)
Sponsor and investigators
- Lead sponsor
- Eunju Lee
- Sponsor type
- University, hospital or other
- Collaborators
- Bodyfriend
- Responsible party
- Sponsor-investigator, Eunju Lee, Asan Medical Center
- Investigators
- Eunju Lee, Principal investigator, Asan Medical Center
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT03732729
- Sponsor's protocol ID
- 2018-1204
- Acronym
- SEAT
- Status last verified
- Jul 2020
- First submitted
- 4 Nov 2018
- Last updated
- 28 Jul 2020
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 28 Jul 2020. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- A Study for Evaluation of Massage Chair in Community-dwelling Older Adults: Randomized Study
- ClinicalTrials.gov ID
- NCT03732729
- Acronym / sponsor ID
- SEAT / 2018-1204
- Conditions
- Older Adults
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 80 participants (actual)
- Lead sponsor
- Eunju LeeUniversity, hospital or other
- Collaborators
- Bodyfriend
- Study start
- 11 Dec 2018 (actual)
- Primary completion
- 16 Apr 2020 (actual)
- Study completion
- 16 Apr 2020 (actual)
- First posted
- 7 Nov 2018 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The use of massage chairs is becoming more popular in many countries. According to the previous reports, some manual massages have positive effects on the mood, pain, fatigue, and sleep quality. However, the clinical benefits of the massage chair have not been fully understood. In this trial, it is aimed to evaluate the clinical effectiveness of the 6-month regular use of massage chair twice a day. It is hypothesized that long-term regular use of massage chair has positive effects on the hormonal level related to the stress, inflammation, and aging, as well as physical, psychologic, and muscle quality.
Detailed description
A total of enrolled 80 patients after randomization(1:1) in intervention(Massage chair)group and Control groups, will be provided
- Massage chair group
- lifestyle modification education + using massage chair twice per day during 24weeks
- control group: only lifestyle modification education
- Screening visit
- collection demographic data, BMD, vital sign, Medication history
- Visit 1 (0-week)
- Vital sign
- Charlson comorbidity index
- Laboratory test
- WBC diff count, Hb, creatinine, ALT, albumin, hsCRP, ESR cortisol, serotonin, DHEA-s, IGF-1, NK cell, Telomere length
- Questionnaire: K-MMSE, SGDS-K, BEPSI-K, EQ-5D-5L
- Physical\& muscular assessment
- SPPB, Grip strength, Muscle tone, Bioimpedance analysis
- Visit 2-6 (4,8,12,16 weeks) via Phone contact: assess compliance and adverse events
- visit 7 (24weeks)
- Vital sign
- Laboratory test
- WBC diff count, Hb, creatinine, ALT, albumin, hsCRP, ESR cortisol, serotonin, DHEA-s, IGF-1, NK cell, Telomere length
- Questionnaire: K-MMSE, SGDS-K, BEPSI-K, EQ-5D-5L
- Physical\& muscular assessment
- SPPB, Grip strength, Muscle tone, Bioimpedance analysis
- Compliance
- Adverse events
Study design
- Primary purpose
- Health services research
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Massage chair | Experimental | Device: massage chairlifestyle modification education(once)+ Using massage chair |
| Control | No intervention | –lifestyle modification education(once) |
Who may qualify
- Ages
- 50 to 75 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (1 listed)
- Community-dwelling healthy adults between 50-75 years old
Key exclusion criteria (9 listed)
- Unable to sign his/her own informed consent
- Any disability or damages in 4 extremity.
- Who have exercised regularly more than twice a week during the last 24 weeks
- Who have received regular massage during the last 24 weeks
- Confirmed osteoporosis of T score <-2.5 from BMD or history of compression fracture
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| massage chairPatient should use massage chair, twice per day, for 30minutes | Device | Massage chair |
Primary outcome
Serum cortisol level
Time frame: Change from baseline serum cortisol level at 24weeks
Investigate serum cortisol level of baseline \& 24weeks between 2 groups.
11 secondary outcomes
Cortisol/DHEA-s ratio
Time frame: Change from Baseline cortisol/DHEA-s ratio level at 24weeks
Serum Serotonin level
Time frame: Change from Baseline serum serotonin level at 24weeks
Serum IGF-1 level
Time frame: Change from Baseline Serum IGF-1 level level at 24weeks
ESR
Time frame: Change from Baseline ESR level at 24weeks
hsCRP
Time frame: Change from Baseline hs CRP level at 24weeks
NK cell activity
Time frame: Change from Baseline NK cell activity level at 24weeks
Telomere length
Time frame: Change from Baseline Telomere length level at 24weeks
Korean version Short form Geriatric Depression Scale(SGDS-K) score
Time frame: SGDS-K summed total score is changed lower at 24weeks from baseline
Korean version -Brief Encounter Psychosocial Instrument(BEPSI-K) score
Time frame: BEPSI-K summed total score is changed lower at 24weeks from baseline
The 5-level EQ-5D version(EQ-5D-5L) score
Time frame: EQ-5D-5L summed total score is changed higher at 24weeks from baseline
Muscle tone score
Time frame: Individual site Muscle tone score is changed higher at 24weeks from baseline
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 28 Jul 2020.
- Individual participant dataSharing planned: No
Related trials for Older Adults
Recruiting
Colon-delivered Riboflavin and Gut Microbiota Composition
Microbiome Dysbiosis, Gut Health
Not yet recruiting
Bispectral Index-Guided Propofol Sedation During Endoscopic Retrograde Cholangiopancreatography
Deep Sedation, Endoscopic Retrograde Cholangiopancreatography
Not yet recruiting
Expanded Diagnostic Strategy in Older Adults Hospitalized With Community-Acquired Acute Respiratory Infection
Acute Respiratory Infection
RecruitingObservational study
Effects of Obesity on Physical Abilities and Daily Living Activities in Elderly Adults
Obesity, Sarcopenic Obesity
RecruitingPhase 2
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Eunju Lee principal investigator
Asan Medical Center
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing massage chair in people with Older Adults, run by Eunju Lee at 1 site in South Korea.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 28 Jul 2020. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in South Korea. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Serum cortisol level (time frame: Change from baseline serum cortisol level at 24weeks). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Jul 2020.